TITLE:
Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Selegiline

SUMMARY:

      The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment
      of cocaine dependence.
    

DETAILED DESCRIPTION:

      The study objectives are to assess the efficacy and safety of the Selegiline Transdermal
      System (STS) in reducing cocaine use in subjects with cocaine dependence. It is hypothesized
      that selegiline treatment compared to placebo, will be associated with fewer days of cocaine
      use as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Male/Female

          -  At least 18 years of age

          -  DSM-4 diagnosis of cocaine dependence

          -  Ability to understand and provide written consent

          -  Female subjects must use acceptable birth control

        Exclusion Criteria:

        - Additional Criteria available during the screening process at the site.
      
